Adrian Rawcliffe

Adrian Rawcliffe

Company: Adaptimmune

Job title: CEO


Industry Leaders’ Fireside Chat: The Future of TCR Therapies 8:30 am

• Current state of the field – various TCR approaches • Future research and development themes • Patient populations and delivery – taking T cell therapy mainstream • Why autologous and allogeneic methods will co-existRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.